Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-15-016366
Filing Date
2015-03-03
Accepted
2015-03-03 19:15:58
Documents
1
Period of Report
2015-02-25

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 6729
  Complete submission text file 0001104659-15-016366.txt   8327
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNERGY PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 2012 NEW YORK NY 10170
Business Address
Griffin Patrick (Reporting) CIK: 0001633942 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35268 | Film No.: 15671284